ARQT
Arcutis Biotherapeutics, Inc.When ARQT passed all Ten ChecksArcutis Biotherapeutics, Inc.
history · not a forecastOver the past 10 years, ARQT has passed all Ten Checks on 2 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +17.9% in Jun 2022, peaked day 9.
- Jun 2022+17.9% -1.9%
- Dec 2020+0.2% -16.3%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about ARQT’s checks
How many technical checks does ARQT pass right now?
As of the Oct 23, 2026 close, ARQT passes 8 of 10 fixed technical checks — the checks not passing: market trend rising, pulled back to support.
Why does ARQT fail the "market trend rising" check?
The S&P 500 ($759.97) is below its 10-day average ($769.33), so the market-trend check fails for every stock today, ARQT included. It clears market-wide when the index reclaims $769.33.
What price would change ARQT's check count?
The nearest flip level is "adequate stop room" fails on a close below $30.61. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.